| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.074 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |